Skip to main content
SpringerLink
Log in

Peripheral DTIC neurotoxicity: a case report

  • Letter to the Editors
  • DTIC Neurotoxicity
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bonadonna G, Zucali R, Monfardini S, DeLena M, Uslenghi C (1975) Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastin and imidazole carboxamide versus MOPP. Cancer 36:252

    Google Scholar 

  2. Comis RL (1976) DTIC (NSC-45388) in malignant melanoma: a perspective. Cancer Treat Rep 60:165

    Google Scholar 

  3. Gams RA, Carpenter JT (1974) Central nervous system complications after conbination treatment with adriamycin (NSC-123127) and 5-(3,3-dimethyl-1-triazeno) inidazole-4-carboxamide (NSC-45388). Cancer Chemother Rep 58: 753

    Google Scholar 

  4. Gerner RE, Moore GE, Didolkar MS (1973) Chemotherapy of disseminated malignant melanoma with dimethyl-triazenoimidazole carboxamide and dactinomycin. Cancer 32: 756

    Google Scholar 

  5. Gottlieb JA, Benjamin RS, Baker LH, O'Bryan RM, Sinkovics JG, Hoogstraten B, Quagliana JM, Rivkin SE, Bodey GP, Rodriguez U, Blumen-Schein GR, Saiki JH, Coltran C, Burgess MA, Sullivan P, Thigpn T, Bottomley R, Balcerzak S, Moon TE (1976) Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. Cancer Treat Rep 60: 199

    Google Scholar 

  6. Kaplan RS, Wiernik PH (1982) Neurotoxicity of antineoplastic drugs. Semin Oncol 9: 103

    Google Scholar 

  7. Paterson AH, McPherson TA (1977) A possible neurologic complication of DTIC. Cancer Treat Rep 61: 105

    Google Scholar 

  8. Schepatz S (1976) History and development of DTIC. Cancer Treat Rep 60:123

    Google Scholar 

  9. See-Lasley K, Ignoffo RJ (1981) Adverse reaction to anticancer drugs. In: Manual of oncology therapeutics. Mosby St Louis, p 249

  10. Shealy YF, Strungk RF, Holum LB, Montgomery JA (1961) Synthesis of potential anticancer agents: 5-diazeno-imidazole-4-carboxamide and 5-diazeno-5-tiazole-4-carboxamide. J Org Chem 26: 2396

    Google Scholar 

  11. Weiss HD, Walker MD, Wiernik PH (1974) Neurotoxicity of commonly used antineoplastic agents. N Engl J Med 291: 75

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncology, S. Chiara Hospital, I-38100, Trento, Italy

    Maurizio Amichetti, Silvano Piffer, Riccardo Valdagni & Giovanni Ambrosini

  2. Department of Neurology, S. Chiara Hospital, I-38100, Trento, Italy

    Marcella Piazza

Authors
  1. Maurizio Amichetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Silvano Piffer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Riccardo Valdagni
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Giovanni Ambrosini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Marcella Piazza
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Amichetti, M., Piffer, S., Valdagni, R. et al. Peripheral DTIC neurotoxicity: a case report. Cancer Chemother. Pharmacol. 19, 87–88 (1987). https://doi.org/10.1007/BF00296264

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00296264

Keywords

Search

Navigation